These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1495978

  • 1. Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.
    Picard S, Parthasarathy S, Fruebis J, Witztum JL.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):6876-80. PubMed ID: 1495978
    [Abstract] [Full Text] [Related]

  • 2. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.
    Scaccini C, Chiesa G, Jialal I.
    J Lipid Res; 1994 Jun 01; 35(6):1085-92. PubMed ID: 8077847
    [Abstract] [Full Text] [Related]

  • 3. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
    Steinbrecher UP, Lougheed M, Kwan WC, Dirks M.
    J Biol Chem; 1989 Sep 15; 264(26):15216-23. PubMed ID: 2768257
    [Abstract] [Full Text] [Related]

  • 4. Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL.
    Philis-Tsimikas A, Parthasarathy S, Picard S, Palinski W, Witztum JL.
    Arterioscler Thromb Vasc Biol; 1995 Mar 15; 15(3):367-76. PubMed ID: 7749847
    [Abstract] [Full Text] [Related]

  • 5. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.
    Hoff HF, O'Neil J, Chisolm GM, Cole TB, Quehenberger O, Esterbauer H, Jürgens G.
    Arteriosclerosis; 1989 Mar 15; 9(4):538-49. PubMed ID: 2751482
    [Abstract] [Full Text] [Related]

  • 6. Aminoguanidine inhibits the modification of proteins by lipid peroxidation derived aldehydes: a possible antiatherogenic agent.
    Requena JR, Vidal P, Cabezas-Cerrato J.
    Diabetes Res; 1992 Mar 15; 20(1):43-9. PubMed ID: 1345001
    [Abstract] [Full Text] [Related]

  • 7. Paradoxical protective effect of aminoguanidine toward low-density lipoprotein oxidation: inhibition of apolipoprotein B fragmentation without preventing its carbonylation. Mechanism of action of aminoguanidine.
    Jedidi I, Thérond P, Zarev S, Cosson C, Couturier M, Massot C, Jore D, Gardès-Albert M, Legrand A, Bonnefont-Rousselot D.
    Biochemistry; 2003 Sep 30; 42(38):11356-65. PubMed ID: 14503886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization.
    Pieri C, Marra M, Gáspár R, Damjanovich S.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):256-60. PubMed ID: 8670192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?
    Bucala R.
    Diabetes Res Clin Pract; 1996 Feb 15; 30 Suppl():123-30. PubMed ID: 8964186
    [Abstract] [Full Text] [Related]

  • 14. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A, Fabjan JS, Tschabuschnig S, Smirnova AV, Horakova L, Hayn M, Auer H, Guttenberger H, Leis HJ, Tatzber F, Waeg G, Schaur RJ.
    Free Radic Biol Med; 1998 May 15; 24(7-8):1139-48. PubMed ID: 9626568
    [Abstract] [Full Text] [Related]

  • 15. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis.
    Chang YC, Huang KX, Huang AC, Ho YC, Wang CJ.
    Food Chem Toxicol; 2006 Jul 15; 44(7):1015-23. PubMed ID: 16473450
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T.
    Atherosclerosis; 2000 Jun 15; 150(2):343-55. PubMed ID: 10856526
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein.
    Ferguson E, Singh RJ, Hogg N, Kalyanaraman B.
    Arch Biochem Biophys; 1997 May 15; 341(2):287-94. PubMed ID: 9169017
    [Abstract] [Full Text] [Related]

  • 18. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S, Barnett J, Fong LG.
    Biochim Biophys Acta; 1990 May 22; 1044(2):275-83. PubMed ID: 2344447
    [Abstract] [Full Text] [Related]

  • 19. Protection of endogenous vitamin E and beta-carotene by aminoguanidine upon oxidation of human low-density lipoproteins by *OH/O(2)*-.
    Lisfi D, Bonnefont-Rousselot D, Fernet M, Jore D, Delattre J, Gardès-Albert M.
    Radiat Res; 2000 May 22; 153(5 Pt 1):497-507. PubMed ID: 10790269
    [Abstract] [Full Text] [Related]

  • 20. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.
    Aviram M, Fuhrman B.
    Mol Cell Biochem; 1998 Nov 22; 188(1-2):149-59. PubMed ID: 9823020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.